ERGOT

Five of ERGOT’s developed transplant models can be found at transplantmodels.com.

Living Donor Risk Index (LKDPI)
This model predicts recipient risk of graft loss after living donor kidney transplantation based on donor characteristics, on the same scale as the KDPI.

ESRD Risk Tool for Kidney Donor Candidates
This model is intended for low-risk adults considering living kidney donation in the United States. It provides an estimate of 15-year and lifetime incidence of end-stage renal disease.

Infectious Risk Donors
When a patient with end stage renal disease (ESRD) on the waitlist for a kidney is offered an Infectious Risk Donor (IRD) kidney, they need to decide whether they will accept the IRD kidney and the associated infectious risk, or if they will decline it and continue to wait for the next available infectious-risk free kidney.

Transplant Candidacy for Patients 65+
This prediction model is intended for adults with ESRD on dialysis aged 65 and above; it provides the predicted probability of 3-year survival after kidney transplantation (KT). Patients with predicted 3-year post-KT survival in the top quintile are deemed “excellent” candidates.

Pediatric Transplant: Living or deceased donor first?
Most pediatric kidney transplant recipients live long enough to require retransplantation. The most beneficial timing for living donor transplantation in candidates with one living donor is not clear.

‘A Risk Index for Living Donor Kidney Transplantation’ in Top 10 of 2016 via AST, ASTS, and AJT

Congratulations to ERGOT’s Dr. Allan Massie, whose article A Risk Index for Living Donor Kidney Transplantation was named one of the Top 10 Accessed Articles in 2016 by AST, ASTS, and AJT!

January 13, 2017 0

Macey Henderson for UNOS Board of Directors!

ERGOT Faculty Macey Henderson, JD PhD has been nominated for UNOS Board of Directors 2017!

A kidney donor herself, Dr. Henderson applies her background in law, ethics, health policy and management to support her research into health outcomes of live kidney donors and transplant patients.

OPTN/UNOS member voting representatives will receive a ballot and biographical information for the nominees in early 2017.

You can follow Macey on twitter @MaceyLHenderson.

January 10, 2017 0

ERGOT Article Listed in ‘Most Accessed Articles of 2016’

Dr. Allan Massie’s A Risk Index for Living Donor Kidney Transplantation was listed as one of the Top 10 Most Accessed Articles of 2016.

Choosing between multiple living kidney donors, or evaluating offers in kidney paired donation, can be challenging because no metric currently exists for living donor quality. Furthermore, some deceased donor (DD) kidneys can result in better outcomes than some living donor kidneys, yet there is no way to compare them on the same scale. To better inform clinical decision-making, we created a living kidney donor profile index (LKDPI) on the same scale as the DD KDPI, using Cox regression and adjusting for recipient characteristics.

The article was published in the July issue of The American Journal of Transplantation.

January 5, 2017 0

Patterns of End-Stage Renal Disease Caused by Diabetes, Hypertension, and Glomerulonephritis in Live Kidney Donors

Completing the trilogy of papers published in the December issue of the American Journal of Transplantation that was dedicated to living donors, our lab looks for Patterns of End-Stage Renal Disease Caused by Diabetes, Hypertension, and Glomerulonephritis in Live Kidney Donors.

We looked at studies averaging less than 10 years of follow-up to better understand postdonation ESRD.

December 15, 2016 0

Smartphone App for Increasing Live Organ Donation

Following the American Journal of Transplantation’s theme of giving for their December article, they published our paper featuring our Smartphone App for Increasing Live Organ Donation.

The idea came from talking to waitlisted candidates for kidney transplant who reported substantial barriers to identifying a live donor. Our app aims to help ESRD patients eligible for transplantation create a dialog that tells their story and helps them reach out to friends and family through social medias.

That app, as of this blog post, is still in development.

December 8, 2016 0

Recipient Outcomes Following Transplantation of Allografts From Live Kidney Donors Who Subsequently Developed End-Stage Renal Disease

The American Journal of Transplantation dedicated their December issue to organ donors who gave the gift of life to over 13,066 people this year (as of 11/18/2016).

At ERGOT, we care about the health and well being of live donors. In Recipient Outcomes Following Transplantation of Allografts From Live Kidney Donors Who Subsequently Developed End-Stage Renal Disease, data shows that preexisting kidney disease might be one mechanism underlying live donor end-stage renal disease.

December 1, 2016 0

Transplant Titan. Renaissance Man.

The Fall 2016 issue of Hopkins Medicine calls him the “Transplant Titan.” We just call him Dorry, and he’s leading a dynamic and life-saving campaign to make organs available to those who need them.

November 22, 2016 0

A Virtual Space for Children with Liver Disease and Their Families

ERGOT’s Douglas Mogul, MD MPH led a team to create the new Facebook application: Liver Space. Mogul wanted to create a community that connected pediatric liver disease patients and their families and provided them with useful information.

“It’s designed to strengthen online communities, serving as a bridge to health care providers and a portal for conducting research,” Mogul told Sarah Richards at Johns Hopkins.

Mogul is currently in talks about creating a similar site for patients with kidney disease.

November 21, 2016 0